Salmonella enterica serovar Typhi and S. Paratyphi A: Need to expand the QRDR region?

Epidemiology and Infection

Volumn 139, Issue 8, 2011, Pages 1281-1283

  Walther Rasmussen, Jan ^a   Høiby, Niels ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); QUINOLONE DERIVATIVE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; ESCHERICHIA COLI; GENETIC DATABASE; LETTER; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; BACTERIAL GENE; DRUG EFFECT; GENETICS; MISSENSE MUTATION; NOTE;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; MUTATION, MISSENSE; QUINOLONES; SALMONELLA PARATYPHI A; SALMONELLA TYPHI;

EID: 80052148818     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810002487     Document Type: Letter

References (10)

1. Capoor MR, et al. Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region? Epidemiology and Infection 2009; 137: 871-878.
2. Drlica K, et al. Quinolones: action and resistance updated. Current Topics in Medicinal Chemistry 2009; 9: 981-998.
3. Hirose K, et al. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistancedetermining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrobial Agents and Chemotherapy 2002; 46: 3249-3252.
4. Izumiya H, et al. Characterization of isolates of Salmonella enterica serovar Typhimurium displaying high-level fluoroquinolone resistance in Japan. Journal of Clinical Microbiology 2005; 43: 5074-5079. (Pubitemid 41484007)
5. Yoshida H, et al. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrobial Agents and Chemotherapy 1990; 34: 1271-1272. (Pubitemid 20177394)
6. Capoor MR, et al. Salmonella enterica serovar Typhi: molecular analysis of strains with decreased susceptibility and resistant to ciprofloxacin in India from 2001-2003. Brazilian Journal of Infectious Diseases 2007; 11: 423-425. (Pubitemid 47516799)
7. Ling JM, et al. Mutations in topoisomerase genes of fluoroquinolone- resistant salmonellae in Hong Kong. Antimicrobial Agents and Chemotherapy 2003; 47: 3567-3573. (Pubitemid 37345721)
8. Eaves DJ, et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrobial Agents and Chemotherapy 2004; 48: 4012-4015. (Pubitemid 39304637)
9. Bendtsen JD, et al. Improved prediction of signal peptides: SignalP 3.0. Journal of Molecular Biology 2004; 340: 783-795. (Pubitemid 38829638)
10. Gardy JL, et al. PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 2005; 21: 617-623. (Pubitemid 40424787)